Article Details
Retrieved on: 2024-08-26 15:17:01
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article examines the market trends, epidemiology, and treatment options for Atypical Hemolytic Uremic Syndrome (aHUS), highlighting therapies like Eculizumab and companies like Alexion Pharmaceuticals. Tags and key concepts align around aHUS, epidemiology, and relevant treatment innovations.
Article found on: www.openpr.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here